SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-423261
Filing Date
2013-11-01
Accepted
2013-11-01 17:25:33
Documents
5
Period of Report
2013-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d619947d8k.htm 8-K 34484
2 EX-3.1 d619947dex31.htm EX-3.1 30161
3 EX-4.1 d619947dex41.htm EX-4.1 284730
4 EX-99.1 d619947dex991.htm EX-99.1 11276
5 GRAPHIC g619947ex991new2.jpg GRAPHIC 9821
  Complete submission text file 0001193125-13-423261.txt   375632
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21696 | Film No.: 131187035
SIC: 2836 Biological Products, (No Diagnostic Substances)